CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia.

Abstract:

:Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with a complex pathogenesis, which includes both antibody- and T-cell-mediated effector mechanisms. Rituximab (an anti-human CD20 monoclonal antibody [mAb]) is one of the treatments for ITP and is known to deplete B cells but may also work by affecting the T-cell compartments. Here, we investigated the outcome of B-cell depletion (Bdep) therapy on CD8(+) T-cell-mediated ITP using a murine model. CD61 knockout (KO) mice were immunized with CD61(+) platelets, and T-cell-mediated ITP was initiated by transfer of their splenocytes into severe combined immunodeficiency (SCID) mice. The CD61 KO mice were administrated an anti-mouse CD20 mAb either before or after CD61(+) platelet immunization. This resulted in efficient Bdep in vivo, accompanied by significant increases in splenic and lymph node CD4(+) and CD8(+) T cells and proportional increases of FOXP3(+) in CD4(+)and CD8(+) T cells. Moreover, Bdep therapy resulted in significantly decreased splenic CD8(+) T-cell proliferation in vitro that could be rescued by interleukin-2. This correlated with normalization of in vivo platelet counts in the transferred SCID mice suggesting that anti-CD20 therapy significantly reduces the ability of CD8(+) T cells to activate and mediate ITP.

journal_name

Blood

journal_title

Blood

authors

Guo L,Kapur R,Aslam R,Speck ER,Zufferey A,Zhao Y,Kim M,Lazarus AH,Ni H,Semple JW

doi

10.1182/blood-2015-06-655126

subject

Has Abstract

pub_date

2016-02-11 00:00:00

pages

735-8

issue

6

eissn

0006-4971

issn

1528-0020

pii

blood-2015-06-655126

journal_volume

127

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

    abstract::Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only potentially curative treatment available for patients with B-cell chronic lymphocytic leukemia (B-CLL). Here, we show that post-alloHSCT antibody repertoires can be mined for the discovery of fully human monoclonal antibodies to B-CLL cell-surfa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-222786

    authors: Baskar S,Suschak JM,Samija I,Srinivasan R,Childs RW,Pavletic SZ,Bishop MR,Rader C

    更新日期:2009-11-12 00:00:00

  • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

    abstract::Numerous studies have suggested that iron (Fe) chelators such as desferrioxamine (DFO) may be useful antitumor agents (Blatt and Stitely, Cancer Res 47:1749, 1987; Becton and Bryles, Cancer Res 48:7189, 1988). Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richardson DR,Tran EH,Ponka P

    更新日期:1995-12-01 00:00:00

  • Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

    abstract::The c-myb proto-oncogene has been implicated in leukemogenesis, but possible mechanisms remain ill defined. To gain further insight to this process, we used transcript profiling in K562 cells expressing a dominant-negative Myb (MERT) protein. A total of 105 potential Myb gene targets were identified. Neuromedin U (NmU...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3577

    authors: Shetzline SE,Rallapalli R,Dowd KJ,Zou S,Nakata Y,Swider CR,Kalota A,Choi JK,Gewirtz AM

    更新日期:2004-09-15 00:00:00

  • The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1.

    abstract::The effect of cyclosporine A (CyA) on the ability of the human immunodeficiency virus type 1 (HIV-1) to infect the H-9 T-cell leukemic line, as well as interleukin-2 (IL-2)-grown human peripheral blood-derived lymphocytes, has been studied. Pretreatment of H-9 cells and human lymphocytes with CyA over 24 hours complet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wainberg MA,Dascal A,Blain N,Fitz-Gibbon L,Boulerice F,Numazaki K,Tremblay M

    更新日期:1988-12-01 00:00:00

  • Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.

    abstract::The interplay between bone marrow stromal cells (BMSCs) and multiple myeloma (MM) cells performs a crucial role in MM pathogenesis by secreting growth factors, cytokines, and extracellular vesicles. Exosomes are membranous vesicles 40 to 100 nm in diameter constitutively released by almost all cell types, and they med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-562439

    authors: Wang J,Hendrix A,Hernot S,Lemaire M,De Bruyne E,Van Valckenborgh E,Lahoutte T,De Wever O,Vanderkerken K,Menu E

    更新日期:2014-07-24 00:00:00

  • Effect of intravenous gammaglobulin on circulating and platelet-bound antibody in immune thrombocytopenia.

    abstract::Ten patients with idiopathic thrombocytopenic purpura (ITP) were studied before and following a rise in circulating platelets subsequent to infusions of intravenous gammaglobulin (400 mg/kg/day x 5 days). We quantitated the amount of circulating IgG capable of binding to normal donor platelets in vitro using an 125I-m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barbano G,Saleh MN,Mori PG,LoBuglio AF,Shaw DR

    更新日期:1989-02-15 00:00:00

  • Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.

    abstract::Fifty-one children with acute lymphoblastic leukemia (ALL) in second or subsequent remission after a first remission of at least 24 months underwent purged, autologous bone marrow transplantation (ABMT). Bone marrow was harvested in remission and purged in vitro with monoclonal antibodies specific for leukemia-associa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billett AL,Kornmehl E,Tarbell NJ,Weinstein HJ,Gelber RD,Ritz J,Sallan SE

    更新日期:1993-03-15 00:00:00

  • T cell chronic lymphocytic leukemia with lymphocytes of unusual immunologic phenotype and function.

    abstract::This report discusses a case of T cell chronic lymphocytic leukemia (T-CLL) in an elderly white man whose lymphocytes expressed a post-thymic phenotype except for the coexpression of T4 and T8 on 80% to 95% of the cells. Because of the uncommon phenotype, in vitro functional assays were performed that showed decreased...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Simpkins H,Kiprov DD,Davis JL 3rd,Morand P,Puri S,Grahn EP

    更新日期:1985-01-01 00:00:00

  • Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

    abstract::The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus-driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328849

    authors: Rigaud S,Lopez-Granados E,Sibéril S,Gloire G,Lambert N,Lenoir C,Synaeve C,Stacey M,Fugger L,Stephan JL,Fischer A,Picard C,Durandy A,Chapel H,Latour S

    更新日期:2011-07-14 00:00:00

  • An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

    abstract::The International Prognostic Index (IPI) has been the basis for determining prognosis in patients with aggressive non-Hodgkin lymphoma (NHL) for the past 20 years. Using raw clinical data from the National Comprehensive Cancer Network (NCCN) database collected during the rituximab era, we built an enhanced IPI with th...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2013-09-524108

    authors: Zhou Z,Sehn LH,Rademaker AW,Gordon LI,Lacasce AS,Crosby-Thompson A,Vanderplas A,Zelenetz AD,Abel GA,Rodriguez MA,Nademanee A,Kaminski MS,Czuczman MS,Millenson M,Niland J,Gascoyne RD,Connors JM,Friedberg JW,Winter JN

    更新日期:2014-02-06 00:00:00

  • A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.

    abstract::An 81-year-old woman, who presented with sudden episodes of spontaneous bleeding, was found to have a specific inhibitor of factor XIII. Her fibrin clots had approximately 70% gamma-gamma and no alpha polymer formation, under conditions where normal fibrin was fully cross-linked; the patient's clots were soluble in ur...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fukue H,Anderson K,McPhedran P,Clyne L,McDonagh J

    更新日期:1992-01-01 00:00:00

  • Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding.

    abstract::The bleeding time is currently the only clinically available comprehensive test to explore primary hemostasis. It is currently performed mostly as a screening procedure before surgery, to detect otherwise unknown defects in platelet-vessel wall interactions, but its use in this specific setting has been seriously ques...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: De Caterina R,Lanza M,Manca G,Strata GB,Maffei S,Salvatore L

    更新日期:1994-11-15 00:00:00

  • Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.

    abstract::Natural killer cells (NK) were studied to determine factors important in their expansion. Flourescence-activated cell sorter (FACS) purified CD56+/CD3- NK cells cultured alone for 18 days in rIL-2 containing medium (1,000 U/mL) showed enhanced cytotoxicity but only minimal expansion. NK expansion was increased (12.5 +...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pierson BA,Gupta K,Hu WS,Miller JS

    更新日期:1996-01-01 00:00:00

  • The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

    abstract::Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and mortality. There are no data addressing individual susceptibility to TA-TMA. We performed a hypothesis-driven analysis of 17 candidate genes known t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-08-663435

    authors: Jodele S,Zhang K,Zou F,Laskin B,Dandoy CE,Myers KC,Lane A,Meller J,Medvedovic M,Chen J,Davies SM

    更新日期:2016-02-25 00:00:00

  • Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists.

    abstract::Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are agonists of the endothelial differentiation gene (Edg) family of G-protein-coupled receptors. LPA and S1P are generated by platelet activation during blood coagulation. Both lipids induce assembly of exogenous fibronectin (FN) by fibroblasts. This study...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.1.117

    authors: Olorundare OE,Peyruchaud O,Albrecht RM,Mosher DF

    更新日期:2001-07-01 00:00:00

  • Selective binding of the factor VIII/von Willebrand factor protein to human platelets.

    abstract::The factor VIII/von Willebrand factor protein was radiolabeled after modification by galactose oxidase and reduction with tritiated potassium borohydride. This mild efficient method for labeling resulted in retention of over 90% of the biologic activities of the factor VIII/von Willebrand factor protein. Binding of th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morisato DK,Gralnick HR

    更新日期:1980-01-01 00:00:00

  • Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.

    abstract::Aneuploidy and lg light chain restriction were used as separate, independent tumor specific markers to study 26 patients with multiple myeloma to determine whether bone marrow B cells, as defined by CD19 expression, are clonally related to myeloma plasma cells. Specimens were characterized using multidimensional flow ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McSweeney PA,Wells DA,Shults KE,Nash RA,Bensinger WI,Buckner CD,Loken MR

    更新日期:1996-07-15 00:00:00

  • Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway.

    abstract::The endogenous presentation of the majority of viral epitopes through MHC class I pathway is strictly dependent on the transporter associated with antigen processing (TAP) complex, which transfers the peptide products of proteasomal degradation into the endoplasmic reticulum. A small number of epitopes can be presente...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-402404

    authors: Tey SK,Khanna R

    更新日期:2012-08-02 00:00:00

  • Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents.

    abstract::Sickle erythrocyte (RBC) membranes were previously shown to manifest increased Fenton activity (iron-dependent, peroxide-driven formation of hydroxyl radical [.OH]) compared with normal RBC membranes, but the nature of the catalytic iron was not defined. We now find that sickle membranes exposed to superoxide (.O2-) a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Repka T,Hebbel RP

    更新日期:1991-11-15 00:00:00

  • Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

    abstract::Burkitt lymphoma (BL) is classified into 3 clinical subsets: endemic, sporadic, and immunodeficiency-associated BL. So far, possible differences in their gene expression profiles (GEPs) have not been investigated. We studied GEPs of BL subtypes, other B-cell lymphomas, and B lymphocytes; first, we found that BL is a u...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-301556

    authors: Piccaluga PP,De Falco G,Kustagi M,Gazzola A,Agostinelli C,Tripodo C,Leucci E,Onnis A,Astolfi A,Sapienza MR,Bellan C,Lazzi S,Tumwine L,Mawanda M,Ogwang M,Calbi V,Formica S,Califano A,Pileri SA,Leoncini L

    更新日期:2011-03-31 00:00:00

  • A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation.

    abstract::Translation of small interfering RNA (siRNA)-based approaches into practical therapeutics is limited because of lack of an effective and cell-specific delivery system. Herein, we present a new method of selectively delivering siRNA to dendritic cells (DCs) in vivo using CD40 siRNA-containing immunoliposomes (siILs) th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151191

    authors: Zheng X,Vladau C,Zhang X,Suzuki M,Ichim TE,Zhang ZX,Li M,Carrier E,Garcia B,Jevnikar AM,Min WP

    更新日期:2009-03-19 00:00:00

  • Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.

    abstract::Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schafer AI,Zavoico GB,Loscalzo J,Maas AK

    更新日期:1987-05-01 00:00:00

  • Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.

    abstract::The pathophysiology of microthrombocytopenia in the Wiskott-Aldrich syndrome (WAS) and its milder form, X-linked thrombocytopenia (XLT), is unclear. Although quantitative defects are correctable by splenectomy, residual platelet abnormalities are suggestive of intrinsic disturbances of production. In contrast to human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-03-1219

    authors: Sabri S,Foudi A,Boukour S,Franc B,Charrier S,Jandrot-Perrus M,Farndale RW,Jalil A,Blundell MP,Cramer EM,Louache F,Debili N,Thrasher AJ,Vainchenker W

    更新日期:2006-07-01 00:00:00

  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

    abstract::Most anticancer chemotherapies are immunosuppressive and induce nonimmunogenic tumor cell death. Bortezomib, a specific inhibitor of 26S proteasome, has shown clinical activity in several human tumors, including myeloma. Here we show that the uptake of human myeloma cells by dendritic cells (DCs) after tumor cell deat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-054221

    authors: Spisek R,Charalambous A,Mazumder A,Vesole DH,Jagannath S,Dhodapkar MV

    更新日期:2007-06-01 00:00:00

  • Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.

    abstract::The anti-CD33 antibody calicheamicinconjugate gemtuzumab ozogamicin (GO) was used to treat 16 patients with acute promyelocytic leukemia (APL) who had relapsed at the molecular level. Of these patients, 8 were experiencing a first, 5 a second, 2 a third, and 1 a fourth relapse. GO was administered at 6 mg/m2 for 2 dos...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-04-1550

    authors: Lo-Coco F,Cimino G,Breccia M,Noguera NI,Diverio D,Finolezzi E,Pogliani EM,Di Bona E,Micalizzi C,Kropp M,Venditti A,Tafuri A,Mandelli F

    更新日期:2004-10-01 00:00:00

  • Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.

    abstract::Targeted irradiation of the bone marrow with radiolabeled monoclonal antibodies (radioimmunotherapy) represents a novel therapeutic approach with both myeloablative and antileukemic potential. In an open-label, single-center pilot study, 30 pediatric and adolescent patients undergoing hematopoietic cell transplantatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-284349

    authors: Schulz AS,Glatting G,Hoenig M,Schuetz C,Gatz SA,Grewendorf S,Sparber-Sauer M,Muche R,Blumstein N,Kropshofer G,Suttorp M,Bunjes D,Debatin KM,Reske SN,Friedrich W

    更新日期:2011-04-28 00:00:00

  • Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.

    abstract::Extracorporeal immunoadsorption of plasma to remove IgG and circulating immune complexes (CIC) was evaluated as a therapy for adults with treatment-resistant immune thrombocytopenic purpura (ITP). Seventy-two patients with initial platelet counts less than 50,000/microL who had failed at least two other therapies were...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Snyder HW Jr,Cochran SK,Balint JP Jr,Bertram JH,Mittelman A,Guthrie TH Jr,Jones FR

    更新日期:1992-05-01 00:00:00

  • Long-term suspension cultures of human cord blood myeloid cells.

    abstract::A method is described that allows for the routine long-term (greater than 3 mo) growth of normal, immature human myeloid cells in liquid suspension culture. The techniques employ cell separation, utilization of special growth conditions (RPMI with hydrocortisone and vitamin D), and cord blood as the source of leukocyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Salahuddin SZ,Markham PD,Ruscetti FW,Gallo RC

    更新日期:1981-11-01 00:00:00

  • Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells.

    abstract::The influence of interferon (IFN) on cellular proliferation, blast transformation, and differentiation was studied in lymph node cells from 17 patients with B-cell lymphomas, one patient with T-cell lymphoma, and eight patients with enlarged, non-malignant lymph nodes. The effects of IFN on lymph node cells were compa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ostlund L,Biberfeld P,Robèrt KH,Christensson B,Einhorn S

    更新日期:1989-06-01 00:00:00

  • von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.

    abstract::Noncovalent association between the von Willebrand factor (VWF) propeptide (VWFpp) and mature VWF aids N-terminal multimerization and protein compartmentalization in storage granules. This association is currently thought to dissipate after secretion into blood. In the present study, we examined this proposition by qu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387548

    authors: Madabhushi SR,Shang C,Dayananda KM,Rittenhouse-Olson K,Murphy M,Ryan TE,Montgomery RR,Neelamegham S

    更新日期:2012-05-17 00:00:00